|
시장보고서
상품코드
2125960
면역혈액학 시장(2026-2030년)Global Immunohematology Market 2026-2030 |
||||||
세계의 면역혈액학 시장은 2025년부터 2030년까지 13억 570만 달러 증가하고, 예측 기간 동안 CAGR은 7.8%에 달할 것으로 예측됩니다.
본 보고서에서는 전 세계 면역혈액학 시장에 대한 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 업체 분석을 제공합니다.
본 보고서는 현재의 시장 상황, 최신 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 견인하는 요인은 전 세계 수술 건수 증가에 따른 검사 수요 확대, 수혈 진단 분야에서의 자동화 도입 확대, 그리고 만성 혈액 질환 유병률의 상승입니다.
본 보고서는 업계 주요 관계자로부터 얻은 정보를 포함하여, 1차 정보와 2차 정보를 객관적으로 결합하여 작성되었습니다. 본 보고서에는 주요 기업에 대한 분석은 물론, 종합적인 시장 규모 데이터, 지역별 분석이 포함된 세분 시장, 그리고 벤더 현황이 수록되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 예측 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 전년 대비(2026년) | 7.2% |
| CAGR | 7.8% |
| 증가액 | 13억 570만 달러 |
본 보고서에서는 복합 적합성 검사의 양상을 완전히 바꾸고 있는 분자 유전자형 분석이 향후 수년간 전 세계 면역혈액학 시장의 성장을 견인할 주요 요인 중 하나라고 규명하고 있습니다. 또한, 범용 기증자 선별과 관련된 규제로 인해 시약 수요가 확대되고 있으며, 응급의료의 확충이 혈청학적 타입 분석의 급속한 보급을 뒷받침하고 있는 점도 시장에서 상당한 수요를 창출하는 요인이 될 것입니다.
목차
제1장 주요 요약
제2장 Technavio에 의한 분석
제3장 시장 구도
제4장 시장 규모 평가
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 제품별
제9장 시장 세분화 : 최종사용자별
제10장 시장 세분화 : 기술별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM 26.09.10The global immunohematology market is forecasted to grow by USD 1305.7 mn during 2025-2030, accelerating at a CAGR of 7.8% during the forecast period. The report on the global immunohematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global surgical volume drives testing, growing automation adoption in transfusion diagnostics, increasing prevalence of chronic hematological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.2% |
| CAGR | 7.8% |
| Incremental Value | $1305.7 mn |
Technavio's global immunohematology market is segmented as below:
By Product
- Analyzers and systems
- Reagents
By End-User
- Hospitals
- Blood banks
- Diagnostic laboratories
By Technology
- Polymerase chain reaction
- Gel cards
- Microplates
- Biochips
- Erythrocyte magenetized
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the molecular genotyping reshaping complex compatibility testing as one of the prime reasons driving the global immunohematology market growth during the next few years. Also, universal donor screening regulations expanding reagent demand and emergency care expansion driving rapid serological typing will lead to sizable demand in the market.
The report on the global immunohematology market covers the following areas:
- Global immunohematology market sizing
- Global immunohematology market forecast
- Global immunohematology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global immunohematology market vendors that include AliveDx, Bio Rad Laboratories Inc., BioMaghreb, DIAGAST SAS, Ebram Produtos Laboratoriais, Fortress Diagnostics, Grifols SA, Hemo bioscience Inc., J. Mitra and Co. Pvt. Ltd., Kinghawk Technology Co. Ltd., Lorne Laboratories Ltd., Medcaptain Medical Technology, Merck KGaA, MTC In Vitro, Origin Biotech, QuidelOrtho Corp., SIFIN Diagnostics GmbH, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., Werfenlife SA. Also, the global immunohematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Immunohematology Market 2020 - 2024
- Historic Market Size - Data Table on Global Immunohematology Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Immunohematology Market
- 6.2 Impact of geopolitical conflicts on Global Immunohematology Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Analyzers and systems - Market size and forecast 2025-2030
- 8.4 Reagents - Market size and forecast 2025-2030
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2025-2030
- 9.4 Blood banks - Market size and forecast 2025-2030
- 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 Polymerase chain reaction - Market size and forecast 2025-2030
- 10.4 Gel cards - Market size and forecast 2025-2030
- 10.5 Microplates - Market size and forecast 2025-2030
- 10.6 Biochips - Market size and forecast 2025-2030
- 10.7 Erythrocyte magenetized - Market size and forecast 2025-2030
- 10.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global surgical volume drives testing
- Growing automation adoption in transfusion diagnostics
- Increasing prevalence of chronic hematological disorders
- 13.2 Market challenges
- High capital costs of immunohematology systems
- Shortage of skilled laboratory technical personnel
- Complex regulatory compliance standards across regions
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Molecular genotyping reshaping complex compatibility testing
- Universal donor screening regulations expanding reagent demand
- Emergency care expansion driving rapid serological typing
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AliveDx
- AliveDx - Overview
- AliveDx - Product / Service
- AliveDx - Key offerings
- SWOT
- 15.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.6 BioMaghreb
- BioMaghreb - Overview
- BioMaghreb - Product / Service
- BioMaghreb - Key offerings
- SWOT
- 15.7 DIAGAST SAS
- DIAGAST SAS - Overview
- DIAGAST SAS - Product / Service
- DIAGAST SAS - Key offerings
- SWOT
- 15.8 Ebram Produtos Laboratoriais
- Ebram Produtos Laboratoriais - Overview
- Ebram Produtos Laboratoriais - Product / Service
- Ebram Produtos Laboratoriais - Key offerings
- SWOT
- 15.9 Fortress Diagnostics
- Fortress Diagnostics - Overview
- Fortress Diagnostics - Product / Service
- Fortress Diagnostics - Key offerings
- SWOT
- 15.10 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
- 15.11 Medcaptain Medical Technology
- Medcaptain Medical Technology - Overview
- Medcaptain Medical Technology - Product / Service
- Medcaptain Medical Technology - Key offerings
- SWOT
- 15.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.13 MTC In Vitro
- MTC In Vitro - Overview
- MTC In Vitro - Product / Service
- MTC In Vitro - Key offerings
- SWOT
- 15.14 Origin Biotech
- Origin Biotech - Overview
- Origin Biotech - Product / Service
- Origin Biotech - Key offerings
- SWOT
- 15.15 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.17 Tulip Diagnostics Pvt. Ltd.
- Tulip Diagnostics Pvt. Ltd. - Overview
- Tulip Diagnostics Pvt. Ltd. - Product / Service
- Tulip Diagnostics Pvt. Ltd. - Key offerings
- SWOT
- 15.18 Werfenlife SA
- Werfenlife SA - Overview
- Werfenlife SA - Product / Service
- Werfenlife SA - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
